Isaac Y Kim
Overview
Explore the profile of Isaac Y Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Piao X, Hwang B, Jeong P, Byun Y, Kang H, Seo S, et al.
Int J Oncol
. 2021 May;
59(1).
PMID: 33982770
The bladder cancer (BCa) microenvironment comprises heterogeneous tumor cell populations, the surrounding stroma and the extracellular matrix (ECM). Collagen, the scaffold of the tumor microenvironment, regulates ECM remodeling to promote...
22.
23.
Leopold Z, Dave P, Menon A, Patel H, Srivastava A, Kim I, et al.
Urol Oncol
. 2021 Feb;
39(8):487-492.
PMID: 33551250
Introduction And Objective: Administrative databases (AD) provide investigators with nationally representative study populations to answer research questions using large sample sizes. We aimed to quantify the trends and incidence of...
24.
Henning G, Vetter J, Sterling J, Andriole G, Kim I, Kim E
Urol Oncol
. 2020 Dec;
39(4):234.e15-234.e19.
PMID: 33353869
Objective: To evaluate the addition of software-assisted fusion magnetic resonance imaging (MRI) targeted biopsy to systematic biopsy and determine clinical and imaging factors associated with improved prostate cancer (PCa) detection....
25.
Srivastava A, Patel H, Kim S, Shinder B, Sterling J, Tabakin A, et al.
Urol Oncol
. 2020 Nov;
39(5):247-257.
PMID: 33223368
Purpose: During COVID-19, many operating rooms were reserved exclusively for emergent cases. As a result, many elective surgeries for renal cell carcinoma (RCC) were deferred, with an unknown impact on...
26.
Shinder B, Patel H, Sterling J, Tabakin A, Kim I, Jang T, et al.
Urol Oncol
. 2020 Jun;
38(7):609-614.
PMID: 32507546
The Coronavirus Disease 2019 pandemic placed urologic surgeons, and especially urologic oncologists, in an unprecedented situation. Providers and healthcare systems were forced to rapidly create triage schemas in order to...
27.
Sterling J, Rivera-Nunez Z, Patel H, Farber N, Kim S, Radadia K, et al.
Clin Genitourin Cancer
. 2020 May;
18(6):e643-e650.
PMID: 32389458
Purpose: To identify factors associated with receipt of partial nephrectomy (PN) and minimally invasive surgery (MIS) in patients with clinical T1 renal cell carcinoma (RCC) using the National Cancer Data...
28.
Kwon Y, Tabakin A, Patel H, Backstrand J, Jang T, Kim I, et al.
Urology
. 2020 Apr;
141:15-19.
PMID: 32339555
No abstract available.
29.
Srivastava A, Rivera-Nunez Z, Kim S, Sterling J, Farber N, Radadia K, et al.
Cancer
. 2020 Apr;
126(13):2991-3001.
PMID: 32329899
Background: Stage III renal cell carcinoma (RCC) encompasses both lymph node-positive (pT1-3N1M0) and lymph node-negative (pT3N0M0) disease. However, prior institutional studies have indicated that among patients with stage III disease,...
30.
Piao X, Jeong P, Yan C, Kim Y, Byun Y, Xu Y, et al.
Oncol Lett
. 2020 Jan;
19(1):476-486.
PMID: 31897161
Screening for genes or markers relevant to bladder cancer (BC) tumorigenesis and progression is of vital clinical significance. The present study used reverse-transcription quantitative PCR reaction assays to examine the...